Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines

por Berruti, A, Bitossi, R, Gorzegno, G, Bottini, A, Generali, D, Milani, M, Katsaros, D, Rigault de la Longrais, I A, Bellino, R, Donadio, M, Ardine, M, Bertetto, O, Danese, S, Sarobba, M G, Farris, A, Lorusso, V, Dogliotti, L
Publicado 2005

Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer

por Oh, S C, Park, K H, Choi, I K, Yoon, S Y, Kim, S J, Seo, J H, Choi, C W, Kim, B S, Shin, S W, Kim, J S, Kim, Y H
Publicado 2005

Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade – results of an explorative CGH meta-analysis

por Moinzadeh, P, Breuhahn, K, Stützer, H, Schirmacher, P
Publicado 2005

Adenoviral vector-mediated expression of a gene encoding secreted, EpCAM-targeted carboxylesterase-2 sensitises colon cancer spheroids to CPT-11

por Oosterhoff, D, Overmeer, R M, de Graaf, M, van der Meulen, I H, Giaccone, G, van Beusechem, V W, Haisma, H J, Pinedo, H M, Gerritsen, W R
Publicado 2005

Ascitic complement system in ovarian cancer

por Bjørge, L, Hakulinen, J, Vintermyr, O K, Jarva, H, Jensen, T S, Iversen, O E, Meri, S
Publicado 2005

Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I study

por Maraveyas, A, Sgouros, J, Upadhyay, S, Abdel-Hamid, A-H, Holmes, M, Lind, M
Publicado 2005

Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer

por Schaefer, C, Kim, G G, Albers, A, Hoermann, K, Myers, E N, Whiteside, T L
Publicado 2005

MET signalling in primary colon epithelial cells leads to increased transformation irrespective of aberrant Wnt signalling

por Boon, E M J, Kovarikova, M, Derksen, P W B, van der Neut, R
Publicado 2005

Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy

por Nurgat, Z A, Craig, W, Campbell, N C, Bissett, J D, Cassidy, J, Nicolson, M C
Publicado 2005

Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations

por Azzabi, A, Hughes, A N, Calvert, P M, Plummer, E R, Todd, R, Griffin, M J, Lind, M J, Maraveyas, A, Kelly, C, Fishwick, K, Calvert, A H, Boddy, A V
Publicado 2005

Over-D1 dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients

por Scartozzi, M, Galizia, E, Graziano, F, Catalano, V, Berardi, R, Baldelli, A M, Testa, E, Mari, D, Silva, R R, Cascinu, S
Publicado 2005

A prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC)

por Senkus-Konefka, E, Dziadziuszko, R, Bednaruk-Młyński, E, Pliszka, A, Kubrak, J, Lewandowska, A, Małachowski, K, Wierzchowski, M, Matecka-Nowak, M, Jassem, J
Publicado 2005

Suicides among Danish cancer patients 1971–1999

por Yousaf, U, Christensen, M-LM, Engholm, G, Storm, H H
Publicado 2005

The psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6-month follow-up

por Maissi, E, Marteau, T M, Hankins, M, Moss, S, Legood, R, Gray, A
Publicado 2005

Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours

por Murai, M, Toyota, M, Satoh, A, Suzuki, H, Akino, K, Mita, H, Sasaki, Y, Ishida, T, Shen, L, Garcia-Manero, G, Issa, J-P J, Hinoda, Y, Tokino, T, Imai, K
Publicado 2005

A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk

por Allen, N E, Roddam, A W, Allen, D S, Fentiman, I S, dos Santos Silva, I, Peto, J, Holly, J M P, Key, T J
Publicado 2005

Waiting times for radiotherapy: variation over time and between cancer networks in southeast England

por Robinson, D, Massey, T, Davies, E, Jack, R H, Sehgal, A, Møller, H
Publicado 2005

Preoperative short-term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II)

por Widder, J, Herbst, F, Dobrowsky, W, Schmid, R, Pokrajac, B, Jech, B, Chiari, C, Stift, A, Maier, A, Karner-Hanusch, J, Teleky, B, Wrba, F, Jakesz, R, Poetter, R
Publicado 2005

NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel

por Hamaguchi, T, Matsumura, Y, Suzuki, M, Shimizu, K, Goda, R, Nakamura, I, Nakatomi, I, Yokoyama, M, Kataoka, K, Kakizoe, T
Publicado 2005

Gene expression profiling of colorectal adenomas and early invasive carcinomas by cDNA array analysis

por Nosho, K, Yamamoto, H, Adachi, Y, Endo, T, Hinoda, Y, Imai, K
Publicado 2005